BIOMAT Database Logo BIOMAT Database Logo

Intracellular pharmacology and biochemistry of methotrexate and 6-mercaptopurine in childhood acute lymphoblastic leukemia. 1994

C W Keuzenkamp-Jansen, and J P Bökkerink, and J M Trijbels, and M A vd Heijden, and R A De Abreu
Center for Pediatric Oncology, University Hospital, Nijmegen, The Netherlands.

UI MeSH Term Description Entries
D007262 Infusions, Intravenous The long-term (minutes to hours) administration of a fluid into the vein through venipuncture, either by letting the fluid flow by gravity or by pumping it. Drip Infusions,Intravenous Drip,Intravenous Infusions,Drip Infusion,Drip, Intravenous,Infusion, Drip,Infusion, Intravenous,Infusions, Drip,Intravenous Infusion
D007963 Leukocytes, Mononuclear Mature LYMPHOCYTES and MONOCYTES transported by the blood to the body's extravascular space. They are morphologically distinguishable from mature granulocytic leukocytes by their large, non-lobed nuclei and lack of coarse, heavily stained cytoplasmic granules. Mononuclear Leukocyte,Mononuclear Leukocytes,PBMC Peripheral Blood Mononuclear Cells,Peripheral Blood Human Mononuclear Cells,Peripheral Blood Mononuclear Cell,Peripheral Blood Mononuclear Cells,Leukocyte, Mononuclear
D008727 Methotrexate An antineoplastic antimetabolite with immunosuppressant properties. It is an inhibitor of TETRAHYDROFOLATE DEHYDROGENASE and prevents the formation of tetrahydrofolate, necessary for synthesis of thymidylate, an essential component of DNA. Amethopterin,Methotrexate Hydrate,Methotrexate Sodium,Methotrexate, (D)-Isomer,Methotrexate, (DL)-Isomer,Methotrexate, Dicesium Salt,Methotrexate, Disodium Salt,Methotrexate, Sodium Salt,Mexate,Dicesium Salt Methotrexate,Hydrate, Methotrexate,Sodium, Methotrexate
D011687 Purines A series of heterocyclic compounds that are variously substituted in nature and are known also as purine bases. They include ADENINE and GUANINE, constituents of nucleic acids, as well as many alkaloids such as CAFFEINE and THEOPHYLLINE. Uric acid is the metabolic end product of purine metabolism.
D011743 Pyrimidines A family of 6-membered heterocyclic compounds occurring in nature in a wide variety of forms. They include several nucleic acid constituents (CYTOSINE; THYMINE; and URACIL) and form the basic structure of the barbiturates.
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002955 Leucovorin The active metabolite of FOLIC ACID. Leucovorin is used principally as an antidote to FOLIC ACID ANTAGONISTS. Calcium Leucovorin,Citrovorum Factor,Folinic Acid,N(5)-Formyltetrahydrofolate,5-Formyltetrahydrofolate,5-Formyltetrahydropteroylglutamate,Calcium Folinate,Folinic Acid-SF,Leucovorin, (D)-Isomer,Leucovorin, (DL)-Isomer,Leucovorin, (R)-Isomer,Leucovorin, Calcium (1:1) Salt,Leucovorin, Calcium (1:1) Salt, (DL)-Isomer,Leucovorin, Calcium (1:1) Salt, Pentahydrate,Leucovorin, Monosodium Salt,Leukovorin,Leukovorum,Wellcovorin,5 Formyltetrahydrofolate,5 Formyltetrahydropteroylglutamate,Acid, Folinic,Factor, Citrovorum,Folinate, Calcium,Folinic Acid SF,Leucovorin, Calcium,Monosodium Salt Leucovorin
D004912 Erythrocytes Red blood cells. Mature erythrocytes are non-nucleated, biconcave disks containing HEMOGLOBIN whose function is to transport OXYGEN. Blood Cells, Red,Blood Corpuscles, Red,Red Blood Cells,Red Blood Corpuscles,Blood Cell, Red,Blood Corpuscle, Red,Erythrocyte,Red Blood Cell,Red Blood Corpuscle
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations

Related Publications

C W Keuzenkamp-Jansen, and J P Bökkerink, and J M Trijbels, and M A vd Heijden, and R A De Abreu
Cellular pharmacology of 6-mercaptopurine in acute lymphoblastic leukemia.
February 1993, The American journal of pediatric hematology/oncology,
C W Keuzenkamp-Jansen, and J P Bökkerink, and J M Trijbels, and M A vd Heijden, and R A De Abreu
Measures of 6-mercaptopurine and methotrexate maintenance therapy intensity in childhood acute lymphoblastic leukemia.
November 2016, Cancer chemotherapy and pharmacology,
C W Keuzenkamp-Jansen, and J P Bökkerink, and J M Trijbels, and M A vd Heijden, and R A De Abreu
Methotrexate pharmacology and resistance in childhood acute lymphoblastic leukemia.
May 1996, Leukemia & lymphoma,
C W Keuzenkamp-Jansen, and J P Bökkerink, and J M Trijbels, and M A vd Heijden, and R A De Abreu
Continuing therapy for childhood acute lymphoblastic leukaemia: clinical and cellular pharmacology of methotrexate, 6-mercaptopurine and 6-thioguanine.
December 2001, Cancer treatment reviews,
C W Keuzenkamp-Jansen, and J P Bökkerink, and J M Trijbels, and M A vd Heijden, and R A De Abreu
The impact of high-dose methotrexate on intracellular 6-mercaptopurine disposition during interval therapy of childhood acute lymphoblastic leukemia.
September 2010, Cancer chemotherapy and pharmacology,
C W Keuzenkamp-Jansen, and J P Bökkerink, and J M Trijbels, and M A vd Heijden, and R A De Abreu
Myelotoxicity, pharmacokinetics, and relapse rate with methotrexate/6-mercaptopurine maintenance therapy of childhood acute lymphoblastic leukemia.
January 1996, Pediatric hematology and oncology,
C W Keuzenkamp-Jansen, and J P Bökkerink, and J M Trijbels, and M A vd Heijden, and R A De Abreu
Prognostic significance of methotrexate and 6-mercaptopurine dosage during maintenance chemotherapy for childhood acute lymphoblastic leukemia.
January 1991, Pediatric hematology and oncology,
C W Keuzenkamp-Jansen, and J P Bökkerink, and J M Trijbels, and M A vd Heijden, and R A De Abreu
[Evaluation of two methods of maintenance chemotherapy with methotrexate and 6-mercaptopurine for childhood acute lymphoblastic leukemia].
June 1984, [Rinsho ketsueki] The Japanese journal of clinical hematology,
C W Keuzenkamp-Jansen, and J P Bökkerink, and J M Trijbels, and M A vd Heijden, and R A De Abreu
Mercaptopurine/Methotrexate maintenance therapy of childhood acute lymphoblastic leukemia: clinical facts and fiction.
October 2014, Journal of pediatric hematology/oncology,
C W Keuzenkamp-Jansen, and J P Bökkerink, and J M Trijbels, and M A vd Heijden, and R A De Abreu
Acute lymphoblastic leukemia and down syndrome: 6-mercaptopurine and methotrexate metabolites during maintenance therapy.
March 2021, Leukemia,
Copied contents to your clipboard!